Hologic wins CE Mark for cervical cancer screening system

By LabPulse.com staff writers

November 17, 2020 -- Hologic has secured the CE Mark for its Genius Digital Diagnostics digital cytology platform for cervical cancer screening. The system combines a new artificial intelligence (AI) algorithm with digital imaging to aid cytotechnologists and pathologists in detecting precancerous lesions and cancer in women.

After analyzing all cells on a ThinPrep Pap test slide, Genius Digital Diagnostics can provide a gallery view of the most diagnostically relevant images, Hologic said.

What's more, it also enables dynamic collaboration across laboratories within a network, connecting pathologists with remote review. Genius Digital Diagnostics comprises a digital imager for image acquisition, an AI algorithm for image analysis, an image management server for storing images, and a review station for case review, according to the company.

Hologic gets CE Mark for breast specimen x-ray system
Hologic has received the CE Mark for its Faxitron Path+ specimen radiography system, which can be used for breast tissue imaging. The system consists...
Hologic scores $119M COVID-19 testing contract
The U.S. government has awarded a $119 million contract to Hologic to expand its production capacity for COVID-19 molecular tests.
Hologic debuts pooling protocol for COVID-19 tests
Hologic has validated the use of its Aptima and Panther Fusion molecular diagnostic COVID-19 assays with pooled patient samples and has also applied for...
Molecular diagnostics sales surge in Hologic's Q3
A strong surge in sales of its molecular diagnostics products helped Hologic offset declines in other areas of the company's business in its third fiscal...

Copyright © 2020 LabPulse.com

Last Updated ls 11/17/2020 5:09:59 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current